Rethinking the syndemic of tuberculosis and dysglycaemia: a Kenyan perspective on dysglycaemia as a neglected risk factor for tuberculosis.
Cheryl KeramaDavid HorneJane Ong'ang'oOmu AnzalaPublished in: Bulletin of the National Research Centre (2023)
Establishing costs of treating TB with diabetes/prediabetes alone and in the additional context of HIV co-infection will inform policy makers on what it takes, financially, to treat these patients and subsidize dysglycaemia care. In Kenya, cardiovascular disease is only rivalled by infectious disease as a cause of mortality, and diabetes is a well-described risk factor for cardiac disease. In poor countries, communicable diseases are responsible for majority of the mortality burden, but societal shifts and rural-urban migration may have contributed to the observed increase of NCDs.
Keyphrases
- cardiovascular disease
- mycobacterium tuberculosis
- type diabetes
- cardiovascular events
- healthcare
- end stage renal disease
- hiv aids
- infectious diseases
- ejection fraction
- chronic kidney disease
- pulmonary tuberculosis
- glycemic control
- newly diagnosed
- public health
- heart failure
- human immunodeficiency virus
- peritoneal dialysis
- south africa
- mental health
- risk factors
- hepatitis c virus
- palliative care
- antiretroviral therapy
- prognostic factors
- cardiovascular risk factors
- hiv positive
- coronary artery disease
- adipose tissue
- metabolic syndrome
- emergency department
- hiv testing
- men who have sex with men